Dr. Boeder is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4168 Front St
San Diego, CA 92103Phone+1 619-543-6303Fax+1 619-543-7277
Education & Training
- University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2015 - 2017
- University of California (San Diego) Medical CenterResidency, Internal Medicine, 2012 - 2015
- Eastern Virginia Medical SchoolClass of 2012
Certifications & Licensure
- CA State Medical License 2014 - 2026
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Publications & Presentations
PubMed
- 4 citationsCombination SGLT2 Inhibitor and Glucagon Receptor Antagonist Therapy in Type 1 Diabetes: A Randomized Clinical Trial.Schafer C Boeder, Robert L Thomas, Melissa J Le Roux, Erin R Giovannetti, Justin M Gregory
Diabetes Care. 2025-01-01 - Acetazolamide Therapy and Kidney Function in Persons with Nonalbuminuric Diabetes Mellitus Type 1.Charles Ginsberg, Jesse C Seegmiller, Volker Vallon, Sami SeungMi Jin, Robert L Thomas
Journal of the American Society of Nephrology. 2024-10-08 - 2 citationsBeta-Hydroxybutyrate Levels and Risk of Diabetic Ketoacidosis in Adults with Type 1 Diabetes Treated with Sotagliflozin.Schafer Boeder, Michael J Davies, Janet B McGill, Richard Pratley, Manon Girard
Diabetes Technology & Therapeutics. 2024-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: